EGFR and colorectal carcinoma: It has been reported that adaptive RAS-MAPK feedback reactivation occurred following KRAS G12C inhibition, and this reactivation may thus lead to KRAS G12C inhibition resistance.13,14 This adaptive feedback is mainly mediated by EGFR and its downstream signaling pathway in CRC.